Details

Last Funding Type

Series B

Last Funding Money Raised

$3.72M

Industries

Artificial Intelligence,Health Care,Medical Device,Wearables,Wireless

Founded date

Jan 1, 2015

Number Of Employee

1 - 10

Operating Status

Active

Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.